You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARQ 092

Showing 1 - 25 of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Proteus Syndrome, PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorders Trial (ARQ 092)

No longer available
  • Proteus Syndrome
  • +2 more
  • ARQ 092
  • (no location specified)
Jul 31, 2021

PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome Trial in Worldwide (Miransertib)

Terminated
  • PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome
  • Atlanta, Georgia
  • +10 more
May 10, 2022

Solid Tumors, Ovarian Cancer, Endometrial Cancer Trial in United States (ARQ 092 + carboplatin + paclitaxel (Closed), ARQ 092 +

Terminated
  • Solid Tumors
  • +2 more
  • ARQ 092 + carboplatin + paclitaxel (Closed)
  • +2 more
  • Grand Rapids, Michigan
  • +4 more
Sep 28, 2020

Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

Completed
  • Proteus Syndrome
  • MK-7075 (miransertib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2022

Proteus Syndrome Trial run by the NHGRI (MK-7075 (miransertib))

Recruiting
  • Proteus Syndrome
  • MK-7075 (miransertib)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Nov 19, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
  • Birmingham, Alabama
  • +91 more
Jan 26, 2023

Seborrheic Dermatitis Trial in United States (ARQ-154)

Completed
  • Seborrheic Dermatitis
  • Beverly Hills, California
  • +38 more
Nov 30, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Active
  • ARQ-151 Vehicle
  • Birmingham, Alabama
  • +75 more
Jan 26, 2023

Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • ARQ-151 0.3% cream
  • ARQ-151 vehicle cream
  • Scottsdale, Arizona
  • +38 more
Dec 5, 2022

Chronic Plaque Psoriasis Trial in Canada, United States (Topical roflumilast)

Enrolling by invitation
  • Chronic Plaque Psoriasis
  • Topical roflumilast
  • Beverly Hills, California
  • +68 more
Nov 9, 2022

Plaque Psoriasis Trial in Worldwide (ARQ-154 foam 0.3%, ARQ-154 vehicle foam)

Completed
Has Results
  • Plaque Psoriasis
  • Roflumilast foam 0.3%
  • Vehicle foam
  • Rogers, Arkansas
  • +46 more
Oct 24, 2022

Seborrheic Dermatitis Trial in Canada, United States (ARQ-154 - Active, ARQ-154 Vehicle)

Completed
  • Seborrheic Dermatitis
  • ARQ-154 - Active
  • ARQ-154 Vehicle
  • Scottsdale, Arizona
  • +52 more
Aug 4, 2022

Seborrheic Dermatitis Trial in Canada, United States (ARQ-154 foam 0.3%, ARQ-154 vehicle foam)

Completed
  • Seborrheic Dermatitis
  • ARQ-154 foam 0.3%
  • ARQ-154 vehicle foam
  • Fremont, California
  • +23 more
Aug 4, 2022

Vitiligo Trial in United States (ARQ-252 cream 0.3%, ARQ-252 Vehicle cream, NB-UVB phototherapy active treatment)

Terminated
  • Vitiligo
  • ARQ-252 cream 0.3%
  • +3 more
  • San Diego, California
  • +4 more
Aug 4, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)

Active, not recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Active
  • ARQ-151 Vehicle
  • Montgomery, Alabama
  • +48 more
Aug 10, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle Cream)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Active
  • ARQ-151 Vehicle Cream
  • Birmingham, Alabama
  • +52 more
Aug 4, 2022

Scalp Psoriasis Trial in Canada, United States (ARQ-154 Foam 0.3%, ARQ-154 Vehicle)

Completed
  • Scalp Psoriasis
  • ARQ-154 Foam 0.3%
  • ARQ-154 Vehicle
  • Scottsdale, Arizona
  • +48 more
Aug 4, 2022

Hematologic Malignancies Trial in Worldwide (Nemtabrutinib)

Recruiting
  • Hematologic Malignancies
  • Torrance, California
  • +51 more
Jan 12, 2023

Psoriasis, Plaque Psoriasis Trial in Canada, Dominican Republic, United States (ARQ-151 cream 0.3%)

Completed
  • Psoriasis
  • Plaque Psoriasis
  • ARQ-151 cream 0.3%
  • Mountain Brook, Alabama
  • +17 more
Aug 2, 2022

Psoriasis, Plaque Psoriasis Trial in Canada, Dominican Republic, United States (ARQ-151 cream 0.3%)

Completed
  • Psoriasis
  • Plaque Psoriasis
  • ARQ-151 cream 0.3%
  • Mountain Brook, Alabama
  • +16 more
Aug 2, 2022

Chronic Plaque Psoriasis Trial in Canada, United States (ARQ-151 0.3% cream, ARQ-151 vehicle cream)

Completed
Has Results
  • Chronic Plaque Psoriasis
  • Roflumilast 0.3% cream
  • Vehicle Cream
  • Encinitas, California
  • +39 more
Dec 5, 2022

Pancreatic Cancer Trial in Baltimore, Dallas (ARQ-761, Gemcitabine, nab-paclitaxel)

Terminated
  • Pancreatic Cancer
  • Baltimore, Maryland
  • +1 more
May 31, 2022

Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)

Completed
Has Results
  • Plaque Psoriasis
  • Roflumilast Cream 0.3%
  • +2 more
  • Beverly Hills, California
  • +29 more
Aug 31, 2022

Solid Tumor, Malignant Lymphoma, Tumor Trial in United States (ARQ 092)

Completed
  • Solid Tumor
  • +2 more
  • ARQ 092
  • Birmingham, Alabama
  • +6 more
Oct 19, 2017

Sarcoma, Stomach Tumors, Tumors Trial run by the NCI (Pazopanib, ARQ 197)

Completed
  • Sarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 23, 2021